Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Paragon CareFRA:PXS +4.23%60 Equity-to-Asset is 0.22 as of Jun. 2026, which is 48% below its 10-year median of 0.42. GuruFocus rates FRA:PXS with a GF Score™ of 60/100 and a GF Value™ of €0.12 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 124 Medical Distribution companies, Paragon Care ranks worse than 77.42% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Paragon Care's Total Stockholders Equity for the quarter that ended in Jun. 2026 was €179 Mil. Paragon Care's Total Assets for the quarter that ended in Jun. 2026 was €832 Mil.
Therefore, Paragon Care's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.22.
The historical rank and industry rank for Paragon Care's Equity-to-Asset or its related term are showing as below:
FRA:PXS'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.17 Med: 0.42 Max: 0.54
Current: 0.22
During the past 13 years, the highest Equity to Asset Ratio of Paragon Care was 0.54. The lowest was 0.17. And the median was 0.42.
FRA:PXS's Equity-to-Asset is ranked worse than 77.42% of 124
companies
in the Medical Distribution industry
Industry Median: 0.395
vs FRA:PXS: 0.22
Paragon Care (FRA:PXS) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Paragon Care Equity-to-Asset Related Terms
Paragon Care Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Paragon Care's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PXS vs MCK, COR, CAH: Equity-to-Asset Comparison
For the Medical Distribution subindustry, Paragon Care's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paragon Care Equity-to-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Paragon Care's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Paragon Care's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Paragon Care's Equity to Asset Ratio for the fiscal year that ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paragon Care (FRA:PXS) has a Equity-to-Asset of 0.22 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Paragon Care and its competitors. This is 48% below median its historical median of 0.42. Over the past decade, Paragon Care's Equity-to-Asset has ranged from 0.17 to 0.54. According to the industry distribution chart, Paragon Care ranks #96 out of 124 companies in the Medical Distribution industry, placing it in the top 77.4%.
Is Paragon Care's Equity-to-Asset too high?
Paragon Care's current Equity-to-Asset of 0.22 is 48% below median its 10-year median of 0.42. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 0.54. The Medical Distribution industry median Equity-to-Asset is 0.40. Paragon Care's value of 0.22 is 44.3% below this industry median. Based on the distribution chart, Paragon Care ranks #96 out of 124 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Paragon Care has a GF Score™ of 60/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Paragon Care's Equity-to-Asset compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Paragon Care ranks #96 out of 124 companies for Equity-to-Asset. This places Paragon Care in the lower half of its industry. The industry median Equity-to-Asset is 0.40. Paragon Care's value of 0.22 is 44.3% below this benchmark. Historically, Paragon Care's own Equity-to-Asset has ranged from 0.17 to 0.54 over the past decade. While the company's 10-year median is 0.42 vs. the industry median of 0.40, Paragon Care has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Distribution company?
The median Equity-to-Asset among Medical Distribution companies is 0.40, based on 124 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Paragon Care's current Equity-to-Asset of 0.22 is 44.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Paragon Care and its competitors. For the Medical Distribution industry, the median Equity-to-Asset is 0.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paragon Care's current Equity-to-Asset is 0.22, which is 48% below median its own 10-year median of 0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paragon Care stock overvalued right now?
Based on GuruFocus' analysis, Paragon Care (FRA:PXS) is currently considered Significantly Undervalued. The stock's GF Value™ is €0.12, compared to a current price of €0.07 — trading 38.3% below its estimated fair value. The current Equity-to-Asset is 0.22, which is 48% below median its 10-year median of 0.42 and 44.3% below the Medical Distribution industry median of 0.40. Paragon Care's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Paragon Care (FRA:PXS), the current Equity-to-Asset is 0.22 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paragon Care (FRA:PXS) Overvalued in 2026?
Based on GuruFocus' analysis, Paragon Care stock appears to be undervalued.
The current stock price of €0.07 is trading 38.3% below its estimated GF Value™ of €0.12.
GuruFocus considers Paragon Care to be Significantly Undervalued.
Key valuation signals for FRA:PXS:
Equity-to-Asset: 0.22 (48% below median its 10-year median of 0.42)
GF Value™: €0.12 vs. price of €0.07 (38.3% below fair value)
Industry Position: 44.3% below the Medical Distribution median (#96 of 124)
No single metric tells the full story. See the FRA:PXS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paragon Care Ltd is a medical device company. The company provides medical equipment, devices, and consumables medical products to the healthcare market. The company provides solutions to various healthcare markets, aged care, and veterinary markets. The group is organized into two operating segments: ParagonCare and CH2 Holdings and the majority of its revenues are generated from the CH2 Holdings segment engaged in the distribution of pharmaceuticals, medical consumables, nutritional, and over-the-counter products to the healthcare market.
60GF Score
Get the complete analysis for FRA:PXS
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PXS has been successfully added to your 
